These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19908069)

  • 21. Treatment of membranous nephropathy.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
    Scolari F; Dallera N; Gesualdo L; Santoro D; Pani A; Santostefano M; Feriozzi S; Mani LY; Boscutti G; Messa P; Magistroni R; Quaglia M; Ponticelli C; Ravani P
    BMJ Open; 2019 Dec; 9(12):e029232. PubMed ID: 31806605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of idiopathic membranous nephropathy (IMN).
    Alexopoulos E; Papagianni A
    Ren Fail; 2000 Nov; 22(6):697-709. PubMed ID: 11104159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrotic syndrome and idiopathic membranous nephropathy associated with autosomal-dominant polycystic kidney disease.
    Peces R; Martínez-Ara J; Peces C; Picazo M; Cuesta-López E; Vega C; Azorín S; Selgas R
    ScientificWorldJournal; 2011 May; 11():1041-7. PubMed ID: 21552769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials.
    Imperiale TF; Goldfarb S; Berns JS
    J Am Soc Nephrol; 1995 Feb; 5(8):1553-8. PubMed ID: 7756587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Habashy D; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
    Ramachandran R; Kumar V; Jha V
    Kidney Int; 2016 Jun; 89(6):1401-2. PubMed ID: 27181781
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
    Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
    Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Membranous kidney diseases in adults].
    Sobarzo Toro M; Vilches A
    Medicina (B Aires); 2004; 64(1):59-65. PubMed ID: 15034960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA; Rovin BH; Agarwal AK; Spetie DN
    Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A; Rasić S; Rebić D; Uncanin S
    Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
    Moroni G; Faricciotti A; Cappelletti M; Ponticelli C
    Nephrol Dial Transplant; 1999 May; 14(5):1303-5. PubMed ID: 10344388
    [No Abstract]   [Full Text] [Related]  

  • 40. Idiopathic membranous nephropathy in children.
    Lee BH; Cho HY; Kang HG; Ha IS; Cheong HI; Moon KC; Lim IS; Choi Y
    Pediatr Nephrol; 2006 Nov; 21(11):1707-15. PubMed ID: 16951933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.